<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: PHGUF.PK News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=phguf.pk</link><description>Latest Financial News for PHARMING GRP NV LEID</description><language>en-us</language><lastBuildDate>Wed, 9 Dec 2009 07:08:00 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>Pharming Confirms Interaction With US FDA for Rhucin (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091209/0567202.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2917871683</guid><pubDate>Wed, 9 Dec 2009 07:08:00 Etc/GMT</pubDate></item><item><title>Pharming to present at Bio-Europe 2009 (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091026/0551587.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3101478647</guid><pubDate>Mon, 26 Oct 2009 17:08:00 Etc/GMT</pubDate></item><item><title>Pharming recombinant human C1 inhibitor: Results in pre-clinical ischaemic reperfusion model confirm potential for new indications (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091022/0550617.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3200847452</guid><pubDate>Thu, 22 Oct 2009 16:48:00 Etc/GMT</pubDate></item><item><title>Q3 2009 PHARMING GROUP NV LEIDEN Earnings Release - Time Not Supplied (CCBN)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20091016.html?t=phguf.pk</link><description></description><guid isPermaLink="false">yahoo_finance/3547220258</guid><pubDate>Fri, 16 Oct 2009 11:07:17 Etc/GMT</pubDate></item><item><title>Pharming announces Third Quarter 2009 Results (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091016/0548215.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/4246551342</guid><pubDate>Fri, 16 Oct 2009 05:05:00 Etc/GMT</pubDate></item><item><title>Pharming confirms successful closing of offer on convertible bonds (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091013/0546934.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/446677945</guid><pubDate>Tue, 13 Oct 2009 16:24:00 Etc/GMT</pubDate></item><item><title>Pharming finalizes conversion of 70% of outstanding bonds (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091008/0545683.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3243883017</guid><pubDate>Thu, 8 Oct 2009 15:56:00 Etc/GMT</pubDate></item><item><title>Pharming secures additional EUR 10 million financing from Yorkville Advisors (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091005/0543922.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/839475570</guid><pubDate>Mon, 5 Oct 2009 05:05:00 Etc/GMT</pubDate></item><item><title>Pharming provides update on outstanding shares (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090930/0542558.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1433455692</guid><pubDate>Wed, 30 Sep 2009 16:37:00 Etc/GMT</pubDate></item><item><title>Pharming receives commitment for conversion of 70% of outstanding bonds (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090930/0542354.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/762040774</guid><pubDate>Wed, 30 Sep 2009 06:07:00 Etc/GMT</pubDate></item><item><title>Pharming&apos;s Marketing Authorisation Application for Rhucin Validated by the European Medicines Agency (EMEA) (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090923/0540395.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2264364801</guid><pubDate>Wed, 23 Sep 2009 21:44:00 Etc/GMT</pubDate></item><item><title>Pharming announces offer to holders of convertible bonds with financial support of current shareholders (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090921/0538982.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3526536566</guid><pubDate>Mon, 21 Sep 2009 05:07:00 Etc/GMT</pubDate></item><item><title>Pharming to present at UBS Global Life Sciences Conference (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090917/0538297.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1444252324</guid><pubDate>Thu, 17 Sep 2009 16:05:00 Etc/GMT</pubDate></item><item><title>DNage initiates observational study in children suffering from Cockayne Syndrome (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090916/0537683.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1947591699</guid><pubDate>Wed, 16 Sep 2009 06:00:00 Etc/GMT</pubDate></item><item><title>Pharming provides update on outstanding number of shares (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090911/0536149.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3771506354</guid><pubDate>Fri, 11 Sep 2009 06:00:00 Etc/GMT</pubDate></item><item><title>Pharming submits marketing authorisation application for Rhucin(R) to the EMEA (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090903/0533824.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/4203360122</guid><pubDate>Thu, 3 Sep 2009 06:07:00 Etc/GMT</pubDate></item><item><title>Pharming gives update on outstanding number of shares (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090828/0531992.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3838970350</guid><pubDate>Fri, 28 Aug 2009 06:07:00 Etc/GMT</pubDate></item><item><title>Pharming Group N.V.: FDA approves Investigational New Drug application for Prodarsan(R) in Cockayne Syndrome patients (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090814/0528115.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3752698766</guid><pubDate>Fri, 14 Aug 2009 08:36:00 Etc/GMT</pubDate></item><item><title>Pharming announces Financial Results First Half Year 2009 (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090717/0519739.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/440625565</guid><pubDate>Fri, 17 Jul 2009 05:07:00 Etc/GMT</pubDate></item><item><title>Pharming provides update on outstanding number of shares (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090714/0518571.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/558712735</guid><pubDate>Tue, 14 Jul 2009 06:05:00 Etc/GMT</pubDate></item></channel></rss><!-- c9.finance.sp2.yahoo.com compressed/chunked Tue Dec 22 19:58:12 PST 2009 -->
